造血干细胞移植中的心血管考虑因素

English | April 19, 2024 | ISBN-10: 3031536584 | 297 pages| PDF (True) | 5 MB

This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities.Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.

这本书讨论了化疗放疗剂的流行病学以及已知的造血干细胞移植（HSCT）中化疗药物的心血管毒性效应，同时也包括了在造血干细胞移植中使用的新型疗法。书中回顾了心脏病和血液科/肿瘤学协会专家共识声明，以患者正在接受的治疗类型为基础对患者的危险分层。最后识别了知识上的空白，并提出了一些研究途径来允许进行更准确的风险评估、预测以及可能减少HSCT患者心血管并发症发生风险的治疗方法。造血干细胞移植中的心血管考量为优化HSCT的短期和长期效果提供了有效的管理图景，这一领域正在迅速发展，对其中的所有相关人员或培训人员都具有相当的兴趣。

---

Download from free file storage

 Download from nitroflare.com  Download from rapidgator.net

---

我要反馈

---

本站不对文件进行储存，仅提供文件链接，请自行下载，本站不对文件内容负责，请自行判断文件是否安全，如发现文件有侵权行为，请联系管理员删除。